Clinical Trials Logo

Citation(s)

A Prospective, Controlled, Interventional Study to Evaluate the Efficacy and Safety of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis

Details for clinical trial NCT04762784